Bangkok Genomics Innovation Public Company LimitedSET: BKGI🇹🇭 TH

Board Performance · 2025

Prevention of Conflicts of Interest

Has the Company Acted to Prevent Conflicts of Interest?

Yes

Operations in the Past Year

The company recognizes the importance of conducting business with integrity, transparency, and accountability, adhering to good corporate governance principles to enhance organizational efficiency. To ensure fair business operations and prevent conflicts of interest, the company has established a Conflict of Interest Prevention Policy, along with strict operational guidelines as follows:

• The company shall not provide loans or guarantees to directors or businesses in which a director holds more than 50% of shares, except as part of company benefits.

• Directors shall not engage in businesses that compete with the company unless approved by the shareholders' meeting before their appointment.

• Directors and executives must not exploit company opportunities or confidential information for personal or third-party benefit, including engaging in competitive or related businesses.

• Directors and executives must not participate in discussions or voting on matters that involve them and could create a conflict of interest with the company. If a transaction is necessary for the company's benefit, it must be conducted on an Arm’s Length Basis as if dealing with an external party.

• Directors and executives must disclose any personal interest in contracts entered into by the company.

• Directors and executives must submit an annual disclosure report on conflicts of interest or whenever a new situation arises.

• Transactions involving the purchase or sale of goods, assets, or other items between a director and the company must be disclosed and approved by the Board of Directors.

• Independent directors must be involved in reviewing and approving conflict-of-interest matters to ensure fair decision-making.

• Directors, executives, and employees who have access to internal information must refrain from misusing such information for personal gain or improperly disclosing it to others.

Ensuring Transparency in Related Transactions, the company places great importance on ensuring transparency and prioritizing the company's best interests when evaluating transactions that may involve conflicts of interest. The company has established the following preventive principles for related-party transactions and intercompany dealings:

1. Directors and executives must disclose to the company any relationships or related transactions that may create a conflict of interest.

2. Avoid engaging in transactions with directors, executives, or related parties that may lead to conflicts of interest with the company. If such transactions are necessary, they must be submitted to the Audit Committee for review before seeking approval from the Board of Directors or the shareholders' meeting (as applicable), in accordance with Securities and Exchange Commission (SEC) and Stock Exchange of Thailand (SET) regulations and good corporate governance principles.

3. Executives and employees must strictly adhere to company regulations and business ethics, ensuring the company maintains its credibility and trustworthiness among all stakeholders. The company actively promotes awareness and compliance among employees through company-wide communication and training.

The company enforces these policies and practices rigorously and transparently to prevent conflicts of interest, ensuring that all business activities are conducted responsibly and in line with the highest ethical standards to build trust among all stakeholders.

Number of Conflict-of-Interest Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to conflicts of interest (cases)000

Prevention of the Use of Inside Information

Has the Company Acted to Prevent the Use of Inside Information?

Yes

Operations in the Past Year

The company conducts its business with a strong focus on shareholders, investors, stakeholders, the economy, and society. To ensure proper governance, the company enforces strict oversight of directors, sub-committee members, executives, and employees in handling non-public internal information and preventing its misuse for personal gain. This is in compliance with the Securities and Exchange Act B.E. 2535 (1992) (including amendments) and the Stock Exchange of Thailand (SET) regulations on information disclosure for listed companies.

Furthermore, the company has implemented an Internal Information Usage Policy, serving as a guideline for managing internal information to ensure that directors, executives, and employees understand and comply with the correct procedures. Over the past year, the company has actively monitored the use of internal information through corporate governance measures, which include: restricting the number of individuals with access to internal information, defining access levels to company information to enhance data security, implementing secure data storage and processing systems Requiring employees to sign confidentiality agreements, informing directors and executives of their responsibilities regarding internal information handling. These measures reinforce the company’s commitment to transparency, data security, and regulatory compliance in managing sensitive corporate information.

Number of Inside-Information Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to the use of inside information to seek benefits (cases)000

Anti-Corruption

Has the Company Acted on Anti-Corruption?

Yes

Operations in the Past Year

The company has established an Anti-Corruption and Fraud Policy as a guideline for conducting business with integrity, emphasizing responsibility towards society and all stakeholders. This policy is implemented within the framework of good corporate governance and ethical business practices, ensuring transparency, strong internal controls, and audit mechanisms to minimize opportunities for fraud and corruption within the organization. To demonstrate its commitment to fighting corruption in all forms, as previously outlined in Section 6.1.2: Policies and Practices Regarding Shareholders and Stakeholders, the company requires that directors, sub-committee members, executives, and employees perform their duties without abusing their authority—directly or indirectly—for personal gain or for the benefit of others through fraudulent means. This includes refraining from soliciting, engaging in, or facilitating corruption in any form that results in undue benefits. The company actively communicates and provides training on its anti-corruption policies and practices to directors, sub-committee members, executives, and employees. Additionally, it has established whistleblowing and complaint channels to report suspected fraudulent or corrupt activities, with confidentiality and protection measures for whistleblowers. If the company detects any bribery, fraud, or corruption, or if any individual is found to have violated the anti-corruption policy, such actions will be considered a serious violation of company regulations and will be subject to disciplinary action. If the act is illegal, the violator may also face legal consequences. As of December 31, 2024, the company has not received any reports of bribery, fraud, or corruption.

Form of Anti-Corruption Operations

Operation
Review of appropriateness in anti-corruption

Number of Corruption Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to corruption (cases)000

Whistleblowing

Has the Company Implemented Whistleblowing Procedures?

Yes

Operations in the Past Year

The company has established a policy on complaints and whistleblowing regarding misconduct, applicable to directors, members of sub-committees, executives, employees, customers, contractors, and stakeholders. The company has set up a reliable process, methods, and channels for employees, customers, contractors, and stakeholders to report any misconduct or wrongdoing they have witnessed or become aware of. Such misconduct may involve directors, sub-committee members, executives, employees, representatives, or agents of the company. Additionally, the company has implemented a policy to protect whistleblowers, witnesses, and other informants from disciplinary actions or other adverse consequences from supervisors or executives. All complaints or whistleblowing reports must be made in good faith and must not be intended as retaliation or malicious accusations. The Board of Directors has established channels for reporting concerns or complaints from stakeholders who believe they have been affected by the company’s operations or have witnessed employees engaging in fraud or illegal activities. Reports can be submitted through the following channels:

(1) Internal Reporting Channels:

Channel 1: Report directly to the supervisor in the chain of command and/or the department responsible for overseeing compliance with the company's code of conduct and ethical standards.

Channel 2: Suggestion Box.

Channel 3: Email: auditcommittee@bangkokgenomics.com.

(2) External Reporting Channels:

Channel 1: By mail, addressed to:

Chairman of the Audit Committee

Bangkok Genomics Innovation Public Company Limited

3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei District, Bangkok 10110, Thailand

Channel 2: By email: auditcommittee@bangkokgenomics.com.

Since the implementation of the whistleblowing policy until December 31, 2024, the company has not received any reports of misconduct or wrongdoing.

Number of Whistleblowing Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues received through whistleblowing channels (cases)000

Selection of Directors & Chief Executives

Are Directors Selected Through the Nomination Committee?

Yes

Are Chief Executives Selected Through the Nomination Committee?

Yes

Number of Directors from Major Shareholders

5

Rights of Minority Shareholders on Director Appointment

The Board of Directors is responsible for nominating and appointing directors, executives with management authority, and heads of key business units. The board establishes policies for recruiting and selecting qualified individuals to serve as directors, members of subcommittees, or senior executives. Candidates undergo background checks and qualification assessments before being presented to the Shareholders' Meeting for approval. The shareholders determine the structure and compensation of the Board, ensuring that it reflects the duties and responsibilities of each director in accordance with the company's charter, policies, regulations, and applicable laws.

The appointment of directors follows the company's articles of association and relevant laws, utilizing the one-share, one-vote principle for director elections. Shareholders may allocate all of their votes to a single candidate or distribute them among multiple candidates but cannot assign varying vote counts to different candidates. In the case of a tie exceeding the number of available board seats, the Chairman of the meeting shall cast the deciding vote. The appointment process must be transparent, considering the nominee’s educational background, experience, and qualifications to ensure an informed decision by the Board and shareholders. Additionally, the right of minority shareholders to nominate individuals for board elections is currently under review.

Method of Director Appointment

Method
Method whereby each director requires approval votes more than half of the votes of attending shareholders with voting rights

Selection of Independent Directors

Criteria for Selecting Independent Directors

The Board of Directors selects independent directors based on their qualifications, work experience, and other relevant factors. The selected candidates are then presented to the shareholders' meeting for appointment as directors of the Company. The Company has a policy to appoint independent directors at a minimum ratio of one-third (1/3) of the total number of directors, with no fewer than three (3) independent directors. Independent directors must be free from the control of management and major shareholders and must not have any financial or operational interests in the Company. Additionally, they must meet all relevant qualifications prescribed by the Capital Market Supervisory Board (SEC) and other applicable laws. Currently, the Board of Directors consists of 11 members, including four (4) independent directors, which is no less than one-third of the total number of directors. The qualifications of the Company’s independent directors can be summarized as follows:

1. Must hold no more than 1% of the total voting shares of the Company, its parent company, subsidiaries, associates, major shareholders, or controlling persons, including shares held by persons related to the independent director.

2. Must not be, nor have ever been, a director involved in management, an employee, a staff member, a salaried advisor, or a controlling person of the Company, its parent company, subsidiaries, associates, subsidiaries of the same tier, major shareholders, or controlling persons. Exceptions apply if such status has been terminated for at least two years before the appointment. However, this restriction does not apply to independent directors who were previously government officials or advisors to a government agency that is a major shareholder or controlling person of the Company.

3. Must not have blood or legal relationships, such as being a parent, spouse, sibling, child, or spouse of a child, of another director, executive, major shareholder, controlling person, or any individual who is nominated to be a director, executive, or controlling person of the Company or its subsidiaries.

4. Must not have or have had any business relationship with the Company, its parent company, subsidiaries, associates, major shareholders, or controlling persons that could interfere with their independent judgment. Additionally, they must not have been a major shareholder or controlling person of the Company unless the relationship ended at least two years before the appointment.

5. May hold directorships in other companies, provided that such positions do not interfere with their responsibilities as an independent director of the Company and comply with the regulations of the Securities and Exchange Commission (SEC) and the Stock Exchange of Thailand (SET).

6. Must not engage in any business that is similar to or competes with the Company’s business, whether as a sole proprietor, partner in a general partnership, unlimited liability partner in a limited partnership, director of a private company, or director of another company conducting similar or competing business, whether for their own benefit or the benefit of others, unless they have disclosed such involvement to the shareholders’ meeting before their appointment.

7. Must meet the independence criteria as prescribed by the Capital Market Supervisory Board and comply with the same standards applicable to audit committee members as specified by the SEC and SET. They must be able to act in the best interests of all shareholders equally, without conflicts of interest. Additionally, they must be able to attend Board meetings and provide independent opinions.

Did Any Independent Director Have a Business or Professional Relationship?

No

Evaluation of Board & Subcommittee Performance

Criteria for Evaluating Board Performance

The company places great importance on good corporate governance policies to foster sustainable growth with a strong emphasis on governance principles. To ensure effective oversight, the company has established charters that define the roles, duties, and responsibilities of the Board of Directors and subcommittees, setting key policies to guide corporate operations. These policies serve as a framework for executives to implement in managing the organization efficiently while adhering to the company's corporate governance standards. To reinforce these governance principles, the Board of Directors and subcommittees conduct self-assessments at least once a year. This evaluation process allows the Board and subcommittees to jointly review their performance, identify areas for improvement, and ensure that their duties, roles, and responsibilities are carried out effectively. The assessment should be conducted at both committee and individual levels to enhance accountability and continuous development.

Evaluation of Board Performance in the Past Year

The results of the Board of Directors’ self-assessment for the year 2025 reflect that, overall, the Board has performed its duties effectively at a good level, particularly in terms of board structure and composition, performance of duties, and meeting effectiveness. Nevertheless, there remain areas for further improvement, including strengthening engagement with management, enhancing the capabilities of directors and executives, and improving overall effectiveness in the performance of duties, in order to further enhance the Company’s corporate governance.

Meeting Attendance & Remuneration

Justification for Directors' Non-Attendance

In 2025, certain directors were unable to attend some Board of Directors’ meetings due to urgent and important business commitments that directly impacted the Company’s direction. Such commitments included meetings and negotiations with key business partners, investors, and strategic partners, which are crucial to the Company’s growth and development. Despite their occasional absence, the directors closely followed the meeting agendas and provided input or comments in advance to ensure continuity in the Board’s operations. The directors remain committed to performing their duties in accordance with good corporate governance principles and continue to place importance on their oversight responsibilities to the fullest extent.

Types of Remuneration of the Board of Directors

At The Annual General Meeting of Shareholders for the year 2025, held on April 28, 2025, resolved to determine the remuneration of the Board of Directors and the sub-committees of the Company as follows:

Monthly Remuneration of the Board of Directors (Baht/person)

• Chairman of the Board 50,000 Baht

• Directors 40,000 Baht

Meeting Allowance for sub-committees (Audit Committee and Executive Committee) (Baht/person)

• Chairman of the Board 20,000 Baht

• Directors 15,000 Baht

Note: Directors who serve as the company's executive shall receive compensation only in their capacity as executives and will not receive any remuneration in their capacity as board members.

Remuneration or Benefits Payable to the Board

MetricAmount (Baht)
Remunerations or benefits pending payment to the board of directors over the past year (baht)0

Supervision of Subsidiaries & Associated Companies

Does the Company Have Subsidiaries or Associated Companies?

Yes

Is There a Mechanism for Overseeing Subsidiaries and Associated Companies?

Yes

Mechanism for Overseeing Management of Subsidiaries

The company has a governance and oversight mechanism for its subsidiaries and affiliated companies by appointing representatives, who are either directors or executives of the company, to serve as directors in all subsidiaries and affiliated companies. This ensures proper supervision and alignment of business operations with the company's core policies while safeguarding the best interests of the subsidiaries and affiliated companies.

Oversight Mechanisms

Mechanism
Sending representatives to act as directors, executives or controlling persons in proportion to shareholdings
Disclosure of financial information and operating results
Transactions between the Company and related persons
Other important transactions

Board Duty Performance — Overview

Board Duty Performance — Overall Description

The Board of Directors has performed its duties effectively, demonstrating strong cooperation and consistent attendance at meetings, while fully carrying out its roles and responsibilities. The results of the Board’s self-assessment reflect a good level of corporate governance. Nevertheless, the Board places importance on continuous improvement, particularly in strengthening engagement with management, enhancing the capabilities of directors and executives, and improving overall effectiveness in the performance of duties.

In addition, the Board has organized a workshop to collaboratively determine strategic directions prior to the preparation and approval of the annual business plan and budget. This allows directors to participate from an early stage and ensures that the plans are comprehensive and aligned with the perspectives of both the Board and management. The Board has also considered key risk issues, such as cyber risk, and deemed it appropriate to invite external experts to provide insights for further consideration.

Furthermore, the Board has established a systematic approach to enhancing its performance by supporting the implementation of an annual strategic planning process and encouraging joint brainstorming sessions between the Board and management to define the Company’s future direction, thereby strengthening corporate governance practices on a continuous basis.

Audit Committee Duty Performance

Results of the Audit Committee's Duty Performance in the Past Year

For the year 2025, ended 31 December 2025, the Audit Committee has fully performed its duties as assigned. The Committee has overseen the Company’s risk management processes to ensure appropriateness and alignment with the evolving business environment. In addition, the Committee has reviewed the adequacy of the internal control system and continuously monitored the remediation of identified deficiencies.

The Audit Committee has reviewed significant transactions to ensure compliance with applicable laws and regulations. It has also overseen the establishment of appropriate, transparent, and auditable whistleblowing and complaint-handling mechanisms. The key activities and significant matters are summarized as follows:

1.Reviewed and examined the Company’s quarterly and annual financial statements to ensure compliance with applicable accounting standards and financial reporting standards issued and revised by the Federation of Accounting Professions, as well as ensuring adequate, accurate, complete, and timely disclosure of material information for decision-making purposes.

2.Reviewed related party transactions between the Company and its connected persons to ensure that such transactions were conducted under normal commercial terms, without any transfer of benefits, and in the best interest of the Company.

3.Reviewed the adequacy and effectiveness of the Company’s internal control and internal audit systems. The Committee monitored the performance of the internal audit function to ensure independence, adherence to professional standards, and effectiveness in providing recommendations to ensure compliance with applicable laws, regulations, policies, and procedures, as well as providing reasonable assurance on the adequacy of the internal control system.

4.Reviewed the adequacy and appropriateness of the Company’s risk management system in accordance with the COSO Enterprise Risk Management – Integrated Framework, covering strategic, financial, operational, and compliance risks, including environmental, reputational, and community-related risks.

5.Promoted and ensured compliance with good corporate governance principles. The Company has continuously adhered to the eight CG principles, including shareholders’ rights and equitable treatment, stakeholder roles, disclosure and transparency, board responsibilities, internal control and risk management, prevention of conflicts of interest, business ethics and code of conduct, and anti-corruption policy. The Board has reviewed and updated the corporate governance policies and practices in accordance with the SEC’s 2018 CG Code, which the Company has implemented effectively, with ongoing improvement plans.

6.Reviewed the Company’s Code of Conduct and ethical standards applicable to directors, executives, and employees.

7.Promoted and ensured compliance with the Company’s Anti-Corruption Policy by directors, executives, and employees.

8.Promoted and ensured that the Company complies with safety standards and maintains a healthy environment for the organization, surrounding communities, and society.

9.Considered and recommended the appointment of the external auditor and the appropriate audit fee for the year, namely Dr.Virach & Associates Office Co., Ltd.

10.Considered and recommended the appointment of the internal control auditor and the appropriate remuneration, namely P&L Internal Audit Co., Ltd.

In the opinion of the Audit Committee, the Company has established adequate and appropriate internal control, risk management, and corporate governance systems for its business operations. No material issues were identified that would affect the reliability of the financial statements or the Company’s operations. The Company’s financial statements have been prepared, in all material respects, in accordance with applicable accounting and financial reporting standards, with appropriate disclosure of related party transactions and potential conflicts of interest. The Company has also maintained an effective risk management system and complied with relevant laws and regulations, while adhering to good corporate governance principles.

Executive Committee Duty Performance

Results of the Executive Committee's Duty Performance in the Past Year

The Executive Committee has performed its duties as assigned effectively by overseeing and monitoring the Company’s operations to ensure alignment with the policies, business plans, and strategies set by the Board of Directors, while optimizing the use of the Company’s resources in accordance with its objectives. The Committee has regularly considered key matters, including the review of annual targets and business plans, monitoring quarterly performance, providing recommendations on management plans, as well as closely monitoring business conditions and market competition.

In addition, the Executive Committee has placed importance on risk management and ensuring that the internal control system is appropriate and adequate. It has also promoted sustainable business development through supporting innovation, developing products and services, and enhancing operational efficiency, while taking into account all stakeholders in a fair and balanced manner. The Executive Committee is of the opinion that the Company’s operations have been conducted in accordance with the established plans and objectives and have supported the Company’s continuous growth.

Contents